JP2007518405A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518405A5
JP2007518405A5 JP2006547602A JP2006547602A JP2007518405A5 JP 2007518405 A5 JP2007518405 A5 JP 2007518405A5 JP 2006547602 A JP2006547602 A JP 2006547602A JP 2006547602 A JP2006547602 A JP 2006547602A JP 2007518405 A5 JP2007518405 A5 JP 2007518405A5
Authority
JP
Japan
Prior art keywords
polynucleotide
recombinant
signal peptide
antigen
bacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006547602A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518405A (ja
JP5532280B2 (ja
Filing date
Publication date
Priority claimed from US10/773,792 external-priority patent/US7691393B2/en
Priority claimed from US10/773,618 external-priority patent/US7833775B2/en
Priority claimed from US10/883,599 external-priority patent/US7695725B2/en
Application filed filed Critical
Priority claimed from PCT/US2004/044080 external-priority patent/WO2005071088A2/en
Publication of JP2007518405A publication Critical patent/JP2007518405A/ja
Publication of JP2007518405A5 publication Critical patent/JP2007518405A5/ja
Application granted granted Critical
Publication of JP5532280B2 publication Critical patent/JP5532280B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006547602A 2003-12-24 2004-12-23 抗原および細菌分泌シグナルポリペプチドを含む融合タンパク質をコードする組換え核酸分子、発現カセット、および細菌、ならびにこれらを使用する方法 Expired - Fee Related JP5532280B2 (ja)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US53259803P 2003-12-24 2003-12-24
US60/532,598 2003-12-24
US54151504P 2004-02-02 2004-02-02
US60/541,515 2004-02-02
US10/773,792 US7691393B2 (en) 2003-02-06 2004-02-06 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof
US10/773,618 2004-02-06
US10/773,618 US7833775B2 (en) 2003-02-06 2004-02-06 Modified free-living microbes, vaccine compositions and methods of use thereof
US10/773,792 2004-02-06
US55674404P 2004-03-26 2004-03-26
US60/556,744 2004-03-26
US10/883,599 US7695725B2 (en) 2003-02-06 2004-06-30 Modified free-living microbes, vaccine compositions and methods of use thereof
US10/883,599 2004-06-30
USPCT/US2004/023881 2004-07-23
PCT/US2004/023881 WO2005009463A2 (en) 2003-07-24 2004-07-23 Antigen-presenting cell vaccines and methods of use thereof
US59937704P 2004-08-05 2004-08-05
US60/599,377 2004-08-05
US61528704P 2004-10-01 2004-10-01
US60/615,287 2004-10-01
US61675004P 2004-10-06 2004-10-06
US60/616,750 2004-10-06
PCT/US2004/044080 WO2005071088A2 (en) 2003-12-24 2004-12-23 Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011115257A Division JP2011155988A (ja) 2003-12-24 2011-05-23 抗原および細菌分泌シグナルポリペプチドを含む融合タンパク質をコードする組換え核酸分子、発現カセット、および細菌、ならびにこれらを使用する方法

Publications (3)

Publication Number Publication Date
JP2007518405A JP2007518405A (ja) 2007-07-12
JP2007518405A5 true JP2007518405A5 (enExample) 2008-02-14
JP5532280B2 JP5532280B2 (ja) 2014-06-25

Family

ID=44588533

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006547602A Expired - Fee Related JP5532280B2 (ja) 2003-12-24 2004-12-23 抗原および細菌分泌シグナルポリペプチドを含む融合タンパク質をコードする組換え核酸分子、発現カセット、および細菌、ならびにこれらを使用する方法
JP2011115257A Withdrawn JP2011155988A (ja) 2003-12-24 2011-05-23 抗原および細菌分泌シグナルポリペプチドを含む融合タンパク質をコードする組換え核酸分子、発現カセット、および細菌、ならびにこれらを使用する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011115257A Withdrawn JP2011155988A (ja) 2003-12-24 2011-05-23 抗原および細菌分泌シグナルポリペプチドを含む融合タンパク質をコードする組換え核酸分子、発現カセット、および細菌、ならびにこれらを使用する方法

Country Status (3)

Country Link
JP (2) JP5532280B2 (enExample)
CN (1) CN1921884B (enExample)
TW (1) TW200530399A (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2535421T3 (es) * 2011-03-22 2015-05-11 Mucosis B.V. Composiciones inmunogénicas en forma particulada y métodos para producir las mismas
CN102766601B (zh) * 2011-11-17 2015-12-16 中山大学肿瘤防治中心 含有可诱导型癌基因的细胞系及其建立方法、应用
EP3763383A1 (en) * 2013-12-16 2021-01-13 Massachusetts Institute Of Technology Micromolded or 3-d printed pulsatile release vaccine formulations
LT3037530T (lt) * 2014-12-22 2017-04-10 Sandoz Ag Sekos variantai
CN105039381B (zh) * 2015-07-21 2018-02-13 齐鲁工业大学 一种麦芽糖诱导型海藻糖合酶合成工程菌及其制备方法与应用
CN107229842A (zh) * 2017-06-02 2017-10-03 肖传乐 一种基于局部图的三代测序序列校正方法
CN115894639B (zh) * 2022-11-03 2024-05-14 大连医诺生物股份有限公司 一种辅助侵染蛋白残基突变体蛋白、其重组体及在外泌酶固定化工艺中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830702A (en) * 1990-10-31 1998-11-03 The Trustees Of The University Of Pennsylvania Live, recombinant listeria monocytogenes and production of cytotoxic T-cell response
FR2686896B1 (fr) * 1992-01-31 1995-01-06 Pasteur Institut Mutant attenue de listeria monocytogenes; souche recombinante de listeria monocytogenes, utilisation comme vecteurs heterologues d'antigenes vaccinal et utilisation comme vaccin ou composition diagnostique.
DE19949594A1 (de) * 1999-10-14 2001-04-26 Deutsches Krebsforsch Rekombinante attenuierte Listerien zur Immuntherapie

Similar Documents

Publication Publication Date Title
EP1303299B1 (en) Use of prokaryotic pest-like peptides for enhancing immunogenicity of antigens
JP2017513502A5 (enExample)
JP2009528065A5 (enExample)
CN106061995A (zh) Uspa2蛋白质构建体及其用途
KR20110045010A (ko) C형 간염의 치료를 위한 조성물 및 방법
WO2012172277A4 (en) Simian adenovirus and hybrid adenoviral vectors
CA2818353A1 (en) Methods and compositions for inducing an immune response to egfrviii
JP2016503655A5 (enExample)
JP2011516070A5 (enExample)
JP2011502165A (ja) 鞭毛細菌に対する免疫応答を強化する組成物および方法
WO2001045639A2 (en) Methods for protecting against lethal infection with bacillus anthracis
AU2014256457A1 (en) Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1
US9982024B2 (en) CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses
JP2007518405A5 (enExample)
AU2017264901A1 (en) Combination prime: boost therapy
JP5097544B2 (ja) 炭疽菌からの防御抗原の調製
JP6213969B2 (ja) 免疫原性ポリペプチド表層発現ビフィズス菌
EP4196158A1 (en) Salmonella vaccine for the treatment of coronavirus
EP2483409B1 (en) LACTOBACILLUS glyceraldehyde-3-phosphate dehydrogenase PROMOTERS AND USES THEREOF
EP2874657B1 (en) Hpv/cyaa-based chimeric proteins and their uses in the induction of immune responses against hpv infection and hpv-induced disorders
RU2006126673A (ru) Рекомбинантные молекулы нуклеиновой кислоты, экспрессирующие кассеты, бактерии и способы их применения
JP2006514606A (ja) 疎水性タンパク質の発現
Chuekwon et al. Immune response to the dual antigen vaccine of Actinobacillus pleuropneumoniae in a mouse model
US20090220517A1 (en) Method for producing epitomers and their uses on carrier microorganisms
HK1208048B (en) Cyaa-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses